Evidence map›Paper›PMID 24462241›Full record

Trial reportJournal of substance abuse treatment2014

Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.

Sandra E Larios, Carmen L Masson, Michael S Shopshire, Jennifer Hettema, Ashly E Jordan, Courtney McKnight, Christopher Young, Mandana Khalili, Randy M Seewald, Albert Min and 4 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance abuse treatment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sandra E LariosUniversity of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA. Electronic address: Sandra.Larios@ucsf.edu.
Carmen L MassonUniversity of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Michael S ShopshireUniversity of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Jennifer HettemaUniversity of Virginia, Department of Psychiatry and Neurobehavioral Sciences, UVA Center for Addiction Research and Education, 2821N. Parham Rd., Suite 203, Richmond, VA 23294, USA.
Ashly E JordanBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Courtney McKnightBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Christopher YoungBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Mandana KhaliliUniversity of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Randy M SeewaldBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Albert MinBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Nicholas HenglUniversity of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
James L SorensenUniversity of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Don C Des JarlaisBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA; Center for Drug Use and HIV Research, 726 Broadway, 10th Floor, New York, NY 10003, USA.
David C PerlmanBeth Israel Medical Center, 1st Ave., New York, NY 10003, USA; Center for Drug Use and HIV Research, 726 Broadway, 10th Floor, New York, NY 10003, USA.
Mount Sinai Beth Israel · USUniversity of California, San Francisco · USUniversity of Virginia · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MEYERHOFF, DIETER J · 1994 to 2014
$28.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Hepatitis Care Coordination in Methadone TreatmentR01DA020841 · NIDA · BETH ISRAEL MEDICAL CTR (NEW YORK) · PI PERLMAN, DAVID C · 2006 to 2010
$1.7M
Hepatitis Care Coordination in Methadone TreatmentR01DA020781 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MASSON, CARMEN L · 2006 to 2010
$1.7M
NIDA NIH HHS P30 DA 011041NIDA NIH HHS P30 DA011041NIDA NIH HHS P50 DA009253NIDA NIH HHS P50DA009253NIDA NIH HHS R01 DA020781NIDA NIH HHS R01DA020781NIDA NIH HHS R01 DA020841NIDA NIH HHS R01DA020841NIDA NIH HHS T32 DA007250NIDA NIH HHS U10 DA015815NIDA NIH HHS U10DA015815NIDA NIH HHS UG1 DA015815NIDDK NIH HHS P30 DK026743NIMHD NIH HHS L60 MD003097
6 · The paper itself

Abstract

The aim of this study was to evaluate the effectiveness of an educational method of providing viral hepatitis education for methadone maintenance patients. Four hundred forty participants were randomly assigned to either a control or a motivationally-enhanced viral hepatitis education and counseling intervention. Viral hepatitis A (HAV), B (HBV), and C (HCV) knowledge tests were administered at baseline, following each of two education sessions (post-education), and at a 3-month follow-up assessment. Results indicated a significant increase in knowledge of HAV, HBV, and HCV over time. No differences were found in knowledge between the intervention groups in knowledge acquisition regarding any of the hepatitis viruses suggesting that a motivational interviewing style may not augment hepatitis knowledge beyond standard counseling. A two-session viral hepatitis education intervention effectively promotes hepatitis knowledge and can be integrated in methadone treatment settings.

Indexed as

Health Knowledge, Attitudes, PracticeAdultCounselingFemaleFollow-Up StudiesHepatitis AHepatitis BHepatitis CHumansMaleMethadoneMiddle AgedMotivational InterviewingOpiate Substitution TreatmentPatient Education as TopicTime FactorsMethadoneEducationHepatitisKnowledgeMethadone

Identifiers

PMID24462241
PMCPMC4019752
OpenAlexW2021771453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.